Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Casein Kinase 2, beta (CSNK2B) (N-Term) Peptide

CSNK2B Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN5511863

Quick Overview for Casein Kinase 2, beta (CSNK2B) (N-Term) Peptide (ABIN5511863)

Target

CSNK2B (Casein Kinase 2, beta (CSNK2B))

Origin

Human

Source

  • 7
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Sequence

    FCEVDEDYIQ DKFNLTGLNE QVPHYRQALD MILDLEPDEE LEDNPNQSDL

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-CSK2B Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    CSNK2B (Casein Kinase 2, beta (CSNK2B))

    Background

    This gene encodes the beta subunit of casein kinase II, a ubiquitous protein kinase which regulates metabolic pathways, signal transduction, transcription, translation, and replication. The enzyme is composed of three subunits, alpha, alpha prime and beta, which form a tetrameric holoenzyme. The alpha and alpha prime subunits are catalytic, while the beta subunit serves regulatory functions. The enzyme localizes to the endoplasmic reticulum and the Golgi apparatus. Two transcript variants encoding different isoforms have been found for this gene.

    Alias Symbols: CSNK2B,CK2N, G5A,

    Protein Size: 215

    Gene ID

    1460

    NCBI Accession

    NP_001311

    UniProt

    P67870
You are here:
Chat with us!